✦ LIBER ✦

Phase II Study of Sunitinib in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

✍ Scribed by Effrosyni Apostolidou; Hagop Kantarjian; Deborah Thomas; Ian Burger; Gautam Borthakur; Srdan Verstovsek

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of 5-azacitidine for pa

✍ Tong, W; Kantarjian, H; Thomas, D; Ravandi, F; Kornblau, S; Manshouri, T; Cortes 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB

A phase II trial of tipifarnib in myelof

✍ Mesa, R A; Camoriano, J K; Geyer, S M; Wu, W; Kaufmann, S H; Rivera, C E; Erlich 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

IDH1 and IDH2 mutation studies in 1473 p

✍ Tefferi, A; Lasho, T L; Abdel-Wahab, O; Guglielmelli, P; Patel, J; Caramazza, D; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 460 KB

Phase II trial of panobinostat, an oral

✍ DeAngelo, Daniel J.; Mesa, Ruben A.; Fiskus, Warren; Tefferi, Ayalew; Paley, Car 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB

Long term molecular responses in a cohor

✍ Stauffer Larsen, Thomas; Iversen, Katrine F.; Hansen, Esben; Mathiasen, Anders B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 618 KB

A higher JAK2 V617F-mutated clone is obs

✍ Bellosillo, B; Martínez-Avilés, L; Gimeno, E; Florensa, L; Longarón, R; Navarro, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 93 KB